BRCA mutation status and determinant of outcome in women with recurrent epithelial ovarian cancer treated with pegylated liposomal doxorubicin

Tamar Safra, Lucia Borgato, Maria Ornella Nicoletto, Linda Rolnitzky, Sharon Pelles-Avraham, Ravit Geva, Martin Edward Donach, John Curtin, Akiva Novetsky, Tal Grenader, Wei Chu V. Lai, Alberto Gabizon, Leslie Boyd, Franco Muggia

Research output: Contribution to journalArticlepeer-review

75 Scopus citations

Fingerprint Dive into the research topics of 'BRCA mutation status and determinant of outcome in women with recurrent epithelial ovarian cancer treated with pegylated liposomal doxorubicin'. Together they form a unique fingerprint.

Medicine & Life Sciences